Art
J-GLOBAL ID:201802222099133913   Reference number:18A0556786

Making Patient-focused Information Provision a Reality: One Company’s Approach

患者思考の情報提供実現のために~企業の取り組みから~
Author (1):
Material:
Volume: 138  Issue:Page: 315-323(J-STAGE)  Publication year: 2018 
JST Material Number: U1399A  ISSN: 1347-5231  Document type: Article
Article type: 解説  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Abstract/Point:
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
In recent years, as the market...
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0556786&from=J-GLOBAL&jstjournalNo=U1399A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Pharmacy in general 
Reference (22):
  • 1) Ministry of Health, Labour and Welfare. Pharmaceutical and Food Safety Bureau/Safety Division Notification No. 0411-1, Evaluation and Licensing Division Notification No. 0411-2, “Iyakuhin risk kanri keikaku shishin ni tsuite,” 11 April, 2012: 〈https://www.pmda.go.jp/files/000145482.pdf〉, cited 4 July, 2017.
  • 2) Pharmaceuticals and Medical Devices Agency. “PMDA ga okonau anzensei joho no shushu/hyoka tenpubunsho no kaitei to risk communication,” 2016: 〈https://www.pmda.go.jp/files/000214660.pdf〉, cited 4 July, 2017.
  • 3) Act on Securing Quality, Efficacy and Safety of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics (Pharmaceuticals, Medical Devices and Other Therapeutic Products Act), 2013.
  • 4) Japan Pharmaceutical Manufacturers Association. “Dai 10 kai kusuri to seiyakusangyo ni kansuru seikatsusha ishikichosa, chosa kekka hokokusho,” 2016: 〈http://www.jpma.or.jp/about/issue/gratis/survey/pdf/10_all.pdf〉, cited 4 July, 2017.
  • 5) Nakayama T., Okugawa S., Nakazawa R., Satomi S., Takemoto S., Ohashi Y., Pharmaceutical and Medical Device Regulatory Science, 46, 438-445 (2015).
more...
Terms in the title (4):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page